Purple Biotech Ltd (PPBT)
NASDAQ: PPBT · Real-Time Price · USD
4.543
-0.047 (-1.02%)
At close: Apr 28, 2026, 4:00 PM EDT
4.320
-0.223 (-4.92%)
After-hours: Apr 28, 2026, 7:17 PM EDT
Purple Biotech Employees
Purple Biotech had 10 employees as of December 31, 2025. The number of employees increased by 1 or 11.11% compared to the previous year.
Employees
10
Change (1Y)
1
Growth (1Y)
11.11%
Revenue / Employee
n/a
Profits / Employee
-$2,638,600
Market Cap
6.28M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 39 |
| Aptevo Therapeutics | 33 |
| FibroBiologics | 15 |
| BioRestorative Therapies | 14 |
| XTL Biopharmaceuticals | 10 |
| Ernexa Therapeutics | 7 |
| Akari Therapeutics, | 6 |
| Can-Fite BioPharma | 5 |
PPBT News
- 6 weeks ago - Purple Biotech Announces CEO Transition - GlobeNewsWire
- 2 months ago - Purple Biotech Announces Plan to Implement ADS Ratio Change - GlobeNewsWire
- 5 months ago - Purple Biotech to Present New Preclinical Data from its CAPTN-3 Tri-Specific Antibody Platform at the European Society of Medical Oncology Immuno-Oncology (ESMO-IO) 2025 Annual Congress - GlobeNewsWire
- 5 months ago - Purple Biotech Reports Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 6 months ago - Purple Biotech Achieves Manufacturing Milestone for IM1240, a Tri-Specific Antibody from the CAPTN-3 Platform - GlobeNewsWire
- 6 months ago - Purple Biotech Announces Receipt of Nasdaq Minimum Bid Price Notification - GlobeNewsWire
- 8 months ago - Purple Biotech Announces Closing of Up To $18 Million Public Offering $6 million upfront with up to an additional $12 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants - GlobeNewsWire
- 8 months ago - Purple Biotech to Participate in the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire